MedTrace Logo

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

NCT00152308 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2020-10-08

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effectively of coating of coronary stents with two different doses of rapamycin for the prevention of coronary vessel re-blockage

Conditions

  • Coronary Disease

Interventions

DEVICE

2% rapamycin-eluting YUKONdes PEARL-stent

DEVICE

1% rapamycin-eluting YUKONdes PEARL-stent

DEVICE

YUKONdes PEARL-stent coated with placebo (ethanol)

Sponsors & Collaborators

  • Translumina GmbH

    lead INDUSTRY

Principal Investigators

  • Albert Schomig, MD · Deutsches Herzzentrum Muenchen

  • Adnan Kastrati, MD · Deutsches Herzzentrum Muenchen

  • Kurt Huber, MD · Wilhelminenspital der Stadt Wien

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2007-02-28

Countries

  • Austria
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00152308 on ClinicalTrials.gov